Clinical Trial Update: Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated safety and feasibility of combining melphalan with palifermin in patients undergoing autologous peripheral stem cell transplant for st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Palifermin (palifermin)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Mucositis, Multiple Myeloma | Phase 1 | Status: COMPLETED